Form 4: Plexus Chairman Foate Sells Shares, Gains RSUs

Plexus Corp.'s Chairman of the Board, Dean A. Foate, reported a sale of 10,000 common shares and the acquisition of 1,008 Restricted Stock Units.

Summary

• Dean A. Foate, Chairman of the Board and Director of Plexus Corp. (PLXS), reported transactions.
• On February 6, 2026, Foate sold 10,000 shares of Plexus Corp. common stock at a price of $205 per share.
• Following this sale, Foate directly beneficially owns 99,429 shares of common stock.
• Foate also indirectly holds 15,000 shares of common stock in a trust.
• On February 9, 2026, Foate acquired 1,008 Restricted Stock Units (RSUs) under the Plexus Corp. 2024 Omnibus Incentive Plan.
• Each RSU represents a contingent right to receive one share of common stock.
• These RSUs are scheduled to vest on February 9, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, reflecting routine insider activity involving both a stock sale for potential liquidity and an RSU grant for future incentive, which is common for executives.

Positives

• Acquisition of 1,008 Restricted Stock Units (RSUs) by the Chairman of the Board, aligning his interests with future company performance.

Negatives

• Sale of 10,000 shares of common stock by the Chairman of the Board at $205 per share.

Future Outlook

The acquired Restricted Stock Units are scheduled to vest on February 9, 2027, indicating a future equity grant realization for the Chairman.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported in a Form 4, provide insights into management's perspective on the company's valuation and future prospects. While a sale might be for personal liquidity, the simultaneous grant of RSUs suggests continued alignment with long-term company performance, a common practice in executive compensation across industries.

Comparison to Industry Standards

• StockSavvy.ai observes that the grant of Restricted Stock Units (RSUs) as part of executive compensation is a standard practice across various industries, including electronics manufacturing services (EMS) where Plexus operates.
• Companies like Jabil Inc. (JBL) and Celestica Inc. (CLS) also frequently utilize RSUs to incentivize long-term performance and align executive interests with shareholder value.
• The vesting schedule of February 9, 2027, for the 1,008 RSUs is typical for such grants, often spanning 1-3 years.
• The sale of 10,000 shares by a director, while notable, is not uncommon for liquidity or portfolio diversification, especially when balanced with new equity grants.

Stakeholder Impact

• Shareholders: The sale could be perceived negatively, but the RSU grant aligns management with future performance.
• Management: The RSU grant provides future equity compensation.

Next Steps

• Vesting of 1,008 Restricted Stock Units on February 9, 2027.

Key Dates

Recommendation

The filing reports a routine insider transaction where the Chairman sold a portion of his common stock holdings but also received a grant of Restricted Stock Units. This suggests a balanced approach to personal liquidity and continued long-term alignment with the company's future. Without additional context on the reasons for the sale or the company's broader performance, a 'hold' recommendation is appropriate, as this filing alone does not present a strong bullish or bearish signal.

Keywords

Plexus Corp, PLXS, Dean A. Foate, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, RSU, Corporate Governance, Director Transaction, Chairman of the Board